Regulation of IL-6 synthesis in human peripheral blood mononuclear cells by C3a and C3a(desArg)

Journal of Immunology

Volumn 162, Issue 1, 1999, Pages 453-459

  Fischer, Wolfgang H ^a,b   Jagels, Mark A ^a   Hugli, Tony E ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPHYLATOXIN; COMPLEMENT COMPONENT C3A; GUANINE NUCLEOTIDE BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOMETACIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROSTAGLANDIN E2;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOMODULATION; MONOCYTE; MONONUCLEAR CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN SECRETION;

AMINO ACID SEQUENCE; CELLS, CULTURED; COMPLEMENT C3A; DINOPROSTONE; HUMANS; INDOMETHACIN; INTERLEUKIN-1; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PERTUSSIS TOXIN; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-1; VIRULENCE FACTORS, BORDETELLA;

EID: 0032964583     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Weinberg, P. F., M. A. Matthay, O. Webster, K. V. Roskos, I. M. Goldstein, and J. F. Murray. 1984. Biologically active products of complement and acute lung injury in patients with sepsis syndrome. Am. Rev. Respir. Dis. 130:791.
2. Bengston, A., and M. Heideman. 1988. Anaphylatoxin formation in sepsis. Arch. Surg. 123:645.
3. Heideman, M., and T. E. Hugli. 1984. Anaphylatoxin generation in multisystem organ failure. J. Trauma 24:1038.
4. Zilow, G., T. Joka, U. Obertacke, U. Rother, and M. Kirschfink. 1992. Generation of anaphylatoxin C3a in plasma and bronchoalveolar lavage fluid in trauma patients at risk for adult respiratory distress syndrome. Crit. Care Med. 20:468.
5. Belmont, H. M., P. Hopkins, H. S. Edelson, H. B. Kaplan, R. Ludewig, G. Weissmann, and S. Abramson. 1986. Complement activation during systemic lupus erythematosus: C3a and C5a anaphylatoxins circulate during exacerbations of disease. Arthritis Rheum. 29:1085.
6. Hugli, T. E. 1981. The structural basis for anaphylatoxin and chemotactic functions of C3a, C4a, and C5a. Crit. Rev. Immunol. 1:321.
7. Hugli, T. E. 1989. Structure and function of C3a anaphylatoxin. Curr. Top. Microbiol. Immunol. 153:181.
8. Köhl, J., and D. Bitter-Suermann. 1993. Anaphylatoxins. In Complement in Health and Disease. K. Whaley, M. Loos, and J. M. Weiler, eds. Kluwer Academic Publishers, Lancaster, pp. 299-324.
9. Goldstein, I. M. 1992. Complement: biologically active products. In Inflammation: Basic Principles and Clinical Correlates. J. I. Gallin, I. M. Goldstein, and R. Snyderman, eds. Raven Press, Ltd. New York.
10. Goodman, M. G., D. E. Chenoweth, and W. O. Weigle. 1982. Induction of interleukin-1 secretion and enhancement of humoral immunity by binding of C5a to macrophage surface C5a receptors. J. Exp. Med. 156:912.
11. Scholz, W., M. R. McClurg, G. J. Cardenas, M. Smith, D. J. Noonan, T. E. Hugli, and E. L. Morgan. 1990. C5a-mediated release of interleukin-6 by human monocytes. Clin. Immunol. Immunopathol. 57:297.
12. Schindler, R., J. A. Gelfand, and C. A. Dinarello. 1990. Recombinant C5a stimulates transcription rather than translation of IL-1 and TNF: translational signal provided by LPS or IL-1 itself. Blood 76:1631.
13. Daffern, P. J., P. H. Pfeifer, J. A. Ember, and T. E. Hugli. 1995. C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation. J. Exp. Med. 181:2119.
14. Morgan, E. L. 1987. The role of prostaglandins in C3a-mediated suppression of human in vitro polyclonal antibody responses. Clin. Immunol. Immunopathol. 44:1.
15. Takabayashi, T., E. Vannier, B. D. Clark, N. H. Margolis, C. A. Dinarello, J. F. Burke, and J. A. Gelfand. 1996. A new biologic role for C3a and C3a desArg: regulation of TNF-alpha and IL-1 beta synthesis. J. Immunol. 156:3455.
16. Nilsson, G., M. Johnell, C. H. Hammer, H. L. Tiffany, K. Nilsson, D. D. Metcalfe, A. Siegbahn, and P. M. Murphy. 1996. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. J. Immunol. 157:1693.
17. Fischer, W. H., and T. E. Hugli. 1997. Regulation of B cell function by C3a and C3adesArg: suppression of TNF-α, IL-6, and the polyclonal immune response. J. Immunol. 159:4279.
18. Van Damme, J., S. Cayphas, G. Opdenakker, A. Billiau, and J. Van Snick. 1987. Interleukin-1 and poly(rl):poly(rC) induce production of a hybridoma growth factor by human fibroblasts. Eur. J. Immunol. 17:1.
19. Sironi, M., F. Breviario, P. Proserpio, A. Biondi, A. Vecchi, J. Van Damme, E. Dejana, and A. Mantovani. 1989. IL-1 stimulates IL-6 production in endothelial cells. J. Immunol. 142:549.
20. Jablons, D. M., J. J. Mule, J. K. Macintosh, P. B. Sehgal, L. T. May, C. M. Huang, S. A. Rosenberg, and M. T. Lotze. 1989. IL-6/IFN-β2 as a circulating hormone: induction by cytokine administration in humans. J. Immunol. 142:1542.
21. Kohase, M., D. Henrikson-DeStefano, L. T. May, J. Vileck, and P. B. Sehgal. 1986. Induction of β2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation. Cell 45:659.
22. Le, J., and J. Vilcek. 1989. Interleukin-6: a multifunctional cytokine regulating immune reaction and the acute phase protein response. Lab. Invest. 61:588.
23. Van Snick, J. 1990. Interleukin-6: An overview. Annu. Rev. Immunol. 8:253.
24. Scholz, W. 1996. Interleukin-6 in diseases: cause or cure? Immunopharmacology 31:131.
25. Paquet, P., and G. E. Pierard. 1996. Interleukin-6 and the skin. Int. Arch. Allergy Immunol. 109:308.
26. Ember, J. A., S. D. Sanderson, T. E. Hugli, and E. L. Morgan. 1994. Induction of Interleukin-8 synthesis from monocytes by human C5a anaphylatoxin. Am. J. Pathol. 144:393.
27. Hugli, T. E., C. Gerard, M. Kawahara, M. E. Scheetz, R. Barton, S. Briggs, G. Koppel, and S. Russell. 1981. Isolation of three separate anaphylatoxins from complement-activated human serum. Mol. Cell. Biochem. 41:59.
28. Dignam, J. P., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475.
29. Kravchenko, V. V., Z. Pan, J. Han, J.-M. Herbert, R. J. Ulevitch, and R. D. Ye. 1995. Platelet-activating factor induces NF-κB activation through a G protein-coupled pathway. J. Biol. Chem. 270:14928.
30. Ember, J. A., N. L. Johansen, and T. E. Hugli. 1991. Designing synthetic super-agonist of C3a anaphylatoxin. Biochemistry 30:3603.
31. Knudsen, P. J., C. A. Dinarello, and T. B. Strom. 1986. Prostaglandins posttranscriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate. J. Immunol. 137:3189.
32. Ames, R. S., H. M. Sarau, P. Nuthulaganti, J. J. Foley, C. Ellis, Z. Zeng, K. Su, A. J. Jurewicz, R. P. Hertzberg, D. J. Bergsma, et al. 1996. Molecular cloning and characterization of the human anaphylatoxin C3a receptor. J. Biol. Chem. 271: 20231.
33. Crass, T., U. Raffetseder, U. Martin, M. Grove, A. Klos, J. Köhl, and W. Bautsch. 1996. Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U-937 cells. Eur. J. Immunol. 26:1944.
34. Shimizu, H., and T. Kishimoto. 1990. Involvement of a NF-κB-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines. Mol. Cell. Biol. 10:561.
35. Libermann, T. A., and D. Baltimore. 1990. Activation of interleukin-6 gene expression through the NF-κB transcription factor. Mol. Cell. Biol. 10:2327.
36. Haegeman, G., J. Content, G. Volkaert, R. Derynck, J. Tavernier, and W. Fiers. 1986. Structural analysis of the sequence encoding for an inducible 26-kDa protein in human fibroblasts. Eur. J. Biochem. 159:625.
37. Haeffner-Cavaillon, N., J. M. Cavaillon, M. Laude, and M. D. Kazatchkine. 1987. C3a (C3ades-Arg) induces production and release of interleukin 1 by cultured human monocytes. J. Immunol. 139:794.
38. Arend, W. R., R. J. Massoni, M. A. Niemann, and P. C. Giclas. 1989. Absence of induction of IL-1 production in human monocytes by complement fragments. J. Immunol. 142:173.
39. desArg regulate Interleukin-6 synthesis in human peripheral blood mononuclear cells. J. Infect. Dis. 177:1622.
40. Fischer, M. B., M. Ma, S. Goerg, X. Zhou, J. Xia, O. Finco, S. Han, G. Kelsoe, R. G. Howard, T. L. Rothstein, et al. 1996. Regulation of the B cell response to T-dependent antigens by classical pathway complement. J. Immunol. 157:549.
41. Donnelly, R. P., L. J. Crofford, S. L. Freeman, J. Buras, E. Remmers, R. L. Wilder, and M. J. Fenton. 1993. Tissue-specific regulation of IL-6 production by IL-4: differential effects of IL-4 on nuclear factor-κB activity in monocytes and fibroblasts. J. Immunol. 151:5603.
42. Roglic, A., E. R. Prossnitz, S. L. Cavanagh, Z. Pan, A. Zou, and R. D. Ye. 1996. cDNA cloning of a novel G protein-coupled receptor with a large extracellular loop structure. Biochim. Biophys. Acta 1305:39.
43. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141.
44. Baeuerle, P. A., and D. Baltimore. 1996. NF-κB: ten years after. Cell 87:13.
45. Sen, R., and D. Baltimore. 1986. Multiple nuclear factors interact with the immunglobulin enhancer sequences. Cell 46:705.
46. Curran, T., and B. R. Franza. 1988. Fos and Jun: the AP-1 connection. Cell 55:395.
47. Kang, S.-H., D. A. Brown, I. Kitajima, X. X., O. Heidenreich, S. Gryaznov, and M. Nerenberg. 1996. Binding and functional effects of transcriptional factor Sp1 on the murine interleukin-6 promotor. J. Biol. Chem. 271:7330.
48. Matsusaka, T., K. Fujikawa, Y. Nishio, N. Mukaida, K. Matsushima, T. Kishimoto, and S. Akira. 1993. Transcription factors NF-IL6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc. Natl. Acad. Sci. USA 90:10193.
49. LeClair, K. P., M. A. Blanar, and P. A. Sharp. 1992. The p50 subunit of NF-κB associates with the NF-IL6 transcription factor. Proc. Natl. Acad. Sci. USA 89: 8145.
50. Fukuoka, Y., and T. E. Hugli. 1988. Demonstration of a specific C3a receptor on guinea pig platelets. J. Immunol. 140:3496.
51. Bokisch, V. A., and H. J. Müller-Eberhard. 1970. Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase. J. Clin. Invest. 49:2427.
52. Zwimer, J., O. Götze, A. Sieber, A. Kapp, G. Begemann, T. Zuberbier, and T. Werfel. 1998. The human mast cell line HMC-1 binds and responds to C3a but not C3a(desArg). Scand. J. Immunol. 47:19.
53. Zwimer, J., O. Götze, A. Mosier, A. Sieber, A. Kapp, G. Begemann, J. Elsner, and T. Werfel. 1997. Blood- and skin-derived monocytes/macrophages respond to C3a but not to C3a(desArg) with a transient release of calcium via a pertussis toxin-sensitive signal transduction pathway. Eur. J. Immunol. 27:2317.
54. Charriaut, C., A. Senik, J.-P. Kolb, M. Barel, and R. Frade. 1982. Inhibition of in vitro natural killer activity by the third component of complement: role for the C3a fragment. Proc. Natl. Acad. Sci. USA 79:6003.
55. Mousli, M., T. E. Hugli, Y. Landry, and C. Bronner. 1992. A mechanism of action for anaphylatoxin C3a stimulation of mast cells. J. Immunol. 148:2456.
56. Erdei, A., and I. Pecht. 1996. Complement peptides and mast cell triggering. Immunol. Lett. 54:109.